Sun Pharma Receives Exchange No-Objection for Promoter Reclassification
Sun Pharmaceutical Industries Ltd has received no-objection letters from both the National Stock Exchange of India (NSE) and BSE Limited (BSE) for the reclassification of certain individuals from the 'Promoter Group' to the 'Public' category. This reclassification is in accordance with Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company had previously intimated about this process on May 14, 22, and 26, 2026. The individuals whose status is being reclassified include Krishna Vrundavandas Valia, Sudhir Vrundavandas Valia, and Raksha Sudhir Valia. Sun Pharma is required to ensure compliance with subsequent disclosure requirements related to this reclassification.
Key Highlights
- Sun Pharma received no-objection from NSE and BSE for promoter reclassification.
- Reclassification moves individuals from 'Promoter Group' to 'Public' category.
- The move is compliant with SEBI Listing Regulations 31A.
- Key individuals affected are Krishna, Sudhir, and Raksha Valia.
- Company must adhere to future disclosure obligations.
Price Impact
More from SUNPHARMA